Pharminent

Poxel’s diabetes drug Imeglimin succeeds in phase 2b study in Japan

Poxel has announced positive top line results of a Phase 2b trial of Imeglimin for type 2 diabetes treatment in Japan. http://contractresearch.pharmaceutical-business-review.com/news/poxels-diabetes-drug-imeglimin-succeeds-in-phase-2b-study-in-japan-050517-5805963

Filed under: Diabetes